Intravenous Iron for Heart Failure: Where Is the Evidence?

28th Annual Heart Failure 2024: An Update on Therapy

I. Pina

Overview Tobacco and Nicotine Dependence

The University of Texas MD Anderson Cancer Center

M. A. Karam Hage, MD

Delayed Diagnosis and Diagnostic Imprinting in Pediatric CNS Tumors:…

Ibrahim Qaddoumi

ASH 2024 Summary: Highlights in AL Amyloidosis and SMM

2024 ASH Annual Meeting Insights Hub

S. Al Hadidi

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Kwok

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Breast Imaging and the Young Patient

Cleveland Clinic Taussig Cancer Institute

L. Dean

Managing Amyloidosis in 2024: Diagnosis and Treatment

Indy Hematology Review

M. Gertz

Managing Dermatologic Toxicities: Cutaneous irAEs Associated with Im…

Cleveland Clinic Taussig Cancer Institute

R. Unwala

Identifying Patients at Risk for Cardiac Toxicity With Cancer Therap…

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

A. Narezkina

Reducing Cardiovascular Risk in Our Patients: Case Presentation

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

A. Narezkina

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

Overview of Iron Deficiency in Heart Failure & Recognizing Iron Defi…

ACHL

M. Vaduganathan

Management of AL Amyloidosis

GRACE

S. Rajeeve

Treatment of Iron Deficiency Across the Heart Failure Spectrum

ACHL

S. Gale